Edition:
India

Constellation Pharmaceuticals Inc (CNST.OQ)

CNST.OQ on NASDAQ Stock Exchange Global Select Market

7.28USD
20 Sep 2019
Change (% chg)

$-0.15 (-2.02%)
Prev Close
$7.43
Open
$7.39
Day's High
$7.50
Day's Low
$7.00
Volume
114,900
Avg. Vol
22,226
52-wk High
$14.04
52-wk Low
$4.01

Latest Key Developments (Source: Significant Developments)

Constellation Pharmaceuticals Q2 Loss Per Share $0.80
Thursday, 8 Aug 2019 

Aug 7 (Reuters) - Constellation Pharmaceuticals Inc ::CONSTELLATION PHARMACEUTICALS ANNOUNCES SECOND-QUARTER AND SIX-MONTH 2019 FINANCIAL RESULTS.Q2 LOSS PER SHARE $0.80.Q2 EARNINGS PER SHARE ESTIMATE $-0.81 -- REFINITIV IBES DATA.PROSTAR STUDY OF CPI-1205 REMAINS ON TRACK, AND IND FOR CPI-0209 WAS FILED AND CLEARED BY FDA.EZH2 FRANCHISE CONTINUES TO ADVANCE.CASH, CASH EQUIVALENTS, AND MARKETABLE SECURITIES AS OF JUNE 30, 2019, WERE $98.1 MILLION.  Full Article

Constellation Pharmaceuticals Says Entered Into A Loan And Security Agreement
Thursday, 21 Mar 2019 

March 21 (Reuters) - Constellation Pharmaceuticals Inc ::CONSTELLATION PHARMACEUTICALS INC - ENTERED INTO A LOAN AND SECURITY AGREEMENT.CONSTELLATION PHARMACEUTICALS INC - TERM LOAN OF UP TO AN AGGREGATE PRINCIPAL AMOUNT OF $40.0 MILLION IS AVAILABLE TO COMPANY.CONSTELLATION PHARMACEUTICALS INC - LOAN AGREEMENT PROVIDES FOR AN INITIAL TERM LOAN ADVANCE OF $20.0 MILLION.CONSTELLATION PHARMACEUTICALS INC - TERM LOAN BEARS INTEREST AT AN ANNUAL RATE EQUAL TO GREATER OF 8.55% AND PRIME RATE OF INTEREST PLUS 2.55%..  Full Article

Constellation Pharmaceuticals Announces Fourth-Quarter And Full-Year 2018 Financial Results
Friday, 15 Mar 2019 

March 14 (Reuters) - Constellation Pharmaceuticals Inc ::CONSTELLATION PHARMACEUTICALS ANNOUNCES FOURTH-QUARTER AND FULL-YEAR 2018 FINANCIAL RESULTS.Q4 LOSS PER SHARE $0.77.Q4 EARNINGS PER SHARE ESTIMATE $-0.74 -- REFINITIV IBES DATA.CASH AND CASH EQUIVALENTS AS OF DECEMBER 31, 2018 DECREASED 10.8% TO $114.6 MILLION COMPARED TO SEPTEMBER 30, 2018.EXPECT THAT CASH AND CASH EQUIVALENTS WILL FUND OPERATING EXPENSES AND CAPEX REQUIREMENTS INTO Q2 OF 2020.  Full Article

Constellation Pharma Inc Says Post-IPO Cash Expected To Fund Operations Into Q2 2020
Monday, 7 Jan 2019 

Jan 7 (Reuters) - Constellation Pharmaceuticals Inc ::CONSTELLATION PHARMACEUTICALS INC - POST-IPO CASH EXPECTED TO FUND OPERATIONS INTO Q2 2020.  Full Article

Constellation Pharma Initiates Phase 2 Portion Of Prostar Clinical Trial In Patients With Type Of Prostate Cancer
Tuesday, 11 Dec 2018 

Dec 10 (Reuters) - Constellation Pharmaceuticals Inc ::CONSTELLATION PHARMACEUTICALS INITIATES PHASE 2 PORTION OF PROSTAR CLINICAL TRIAL IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC).CONSTELLATION PHARMACEUTICALS INC - PRELIMINARY PHASE 1B RESULTS SUGGEST CPI-1205 IS WELL-TOLERATED.CONSTELLATION PHARMACEUTICALS INC - CONTINUES TO EXPECT TO DETERMINE PROOF OF CONCEPT FOR CPI-1205 IN MID-2019..  Full Article

Constellation Pharmaceuticals Reports Q3 Loss Per Share Of $0.81
Friday, 9 Nov 2018 

Nov 8 (Reuters) - Constellation Pharmaceuticals Inc ::CONSTELLATION PHARMACEUTICALS ANNOUNCES THIRD-QUARTER AND NINE-MONTH 2018 FINANCIAL RESULTS.Q3 LOSS PER SHARE $0.81.Q3 EARNINGS PER SHARE VIEW $-0.67 -- THOMSON REUTERS I/B/E/S.EXPECTS TO EVALUATE PROOF OF CONCEPT FOR CPI-1205 AND CPI-0610 PROGRAMS IN MID-2019.CONSTELLATION PHARMACEUTICALS - EXPECT CASH AS OF SEPT 30, 2018, WILL FUND PLANNED OPERATIONS INTO Q1 2020.  Full Article

Constellation Pharmaceuticals Shares Debut At $11.48, About 23 Pct Below IPO Price
Thursday, 19 Jul 2018 

July 19 (Reuters) - :CONSTELLATION PHARMACEUTICALS SHARES DEBUT AT $11.48 ON NASDAQ VERSUS IPO PRICE OF $15.00/SHARE.  Full Article

Constellation Pharmaceuticals Announces Pricing Of Initial Public Offering
Thursday, 19 Jul 2018 

July 18 (Reuters) - Constellation Pharmaceuticals Inc ::CONSTELLATION PHARMACEUTICALS ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING.SAYS INITIAL PUBLIC OFFERING OF 4.00 MILLION COMMON SHARES PRICED AT $15.00PER SHARE.  Full Article

Constellation Pharma Sees IPO Of 5.3 Mln Shares Priced $14-$16 Per Share
Monday, 9 Jul 2018 

July 9 (Reuters) - Constellation Pharmaceuticals Inc ::CONSTELLATION PHARMACEUTICALS INC - SEES IPO OF 5.3 MILLION SHARES OF COMMON STOCK PRICED BETWEEN $14.00 AND $16.00 PER SHARE.  Full Article